Cidara Therapeutics Inc.

(CDTX) Trade

By |

Profile

Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's main drug constitutes echinocandins antifungals in the form of CD101IV and CD101 topical. It has developed a proprietary immunotherapy technology platform, Cloudbreak, which is used to create compounds designed to direct a patient's immune cells to attack and eliminate pathogens that cause infectious diseases.

Contact Information

Website: www.cidara.com
Email: info@cidara.com
Main Phone: +1 858 752-6170
Address: 6310 Nancy Ridge Drive
Address 2: Suite 101
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: NSD
CEO: Jeffrey Stein
Employees: 68
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's main drug constitutes echinocandins antifungals in the form of CD101IV and CD101 topical. It has developed a proprietary immunotherapy technology platform, Cloudbreak, which is used to create compounds designed to direct a patient's immune cells to attack and eliminate pathogens that cause infectious diseases.

Contact Information

Website: www.cidara.com
Email: info@cidara.com
Main Phone: +1 858 752-6170
Address: 6310 Nancy Ridge Drive
Address 2: Suite 101
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: NSD
CEO: Jeffrey Stein
Employees: 68
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 3.63 $ 0.06 (1.68%)
Last Price 3.63 Change $ 0.06 Change % 1.68 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 3.60 High 3.68 Low 3.35 Prev Close 3.57
Last Trade Volume 181,584 52 Wk Hi 4.45 52 Wk Low 1.23
Market Cap 147.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 40,746,530.00 EPS (TTM) -1.20 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 7
Number of Buys 1 7
Number of Sells 0 0
Net Activity 212766 285116
Last 10 Buys Shares
Jeffrey Stein 1,000
Jeffrey Stein 1,000
Taylor Sandison 1,000
Taylor Sandison 1,000
Jeffrey Stein 1,000
Kevin Forrest 1,000
Jeffrey Stein 1,000
Jeffrey Stein 1,000
Kevin Forrest 1,000
Jeffrey Stein 1,000
Last 10 Sell Shares
Patrick J. Heron 1,000
Patrick J. Heron 1,000
Patrick J. Heron 1,000
Patrick J. Heron 1,000
Patrick J. Heron 1,000
Patrick J. Heron 1,000
Patrick J. Heron 1,000
Patrick J. Heron 1,000
Patrick J. Heron 1,000
Patrick J. Heron 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 20 20 20
Low Target Price Estimate 11.25 11.25 11.25 9.25
Mean Target Price Estimate 14.85 14.85 15.65 14.45
Standard Deviation 3.5 3.5 3.12 4.08
Date of Most Recent Estimate 05/25/18 05/25/18 05/22/18 06/12/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1.33 1.33 1.33